A Companion study for patient who completed participation in a REGN2810 study

Clinical Trial Grant

Duke Scholars

Principal Investigator Herbert Ira Hurwitz Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

May 1, 2016

End Date

February 20, 2018

Administered By

Duke Cancer Institute

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

May 1, 2016

End Date

February 20, 2018